+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Single-use Bioprocessing Systems Market - Global & North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4852024
  • Report
  • December 2018
  • Region: Global
  • 215 pages
  • Transparency Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

Single-use Bioprocessing Systems Market - Overview

Bioprocessing is a significant part of biopharmaceutical development and production processes. Single-use bioprocessing systems, which are meant for one-time use, have captured a unique position in the biopharmaceutical and bio therapeutics industries. Biomanufacturing facilities which once housed only stainless steel equipment are paving the way for a hybrid setup which also incorporates single-use technologies. New facilities manufacturing biologics, especially CROs/CMOs and small biotechnology startups, are increasingly opting for fully single-use plants. These systems have made the production of clinical trial drugs as well as commercially manufactured drugs cost-effective and flexible. The global single-use bioprocessing systems market is expected to register double-digit growth during the forecast period from 2018 to 2026. This is attributed to lowered labor efforts, lowered capital cost, and reduction in time, money, and efforts spent on sterilization procedures.

This report on the global single-use bioprocessing systems market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the overview section. Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. Market related factors such as technological developments, product innovation, expansion of infrastructural facilities by major & small pharmaceuticals, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment of the global single-use bioprocessing systems market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, drug development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Based on product type, the global single-use bioprocessing systems market has been segmented into bioreactors & fermenters, mixers, bags, filtration devices, tubing, sampling systems, connectors & clamps, and sensors & probes. Bags and bioreactors are the most prominently used products in the global market. Major end-users of single-use bioprocessing systems include pharmaceutical organizations, biotechnology organizations, CROs & CMOs, and academic and research institutes. In terms of application, the market has been segmented into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. The others segment includes recombinant proteins, enzymes, and growth factors. The flexibility of single-use systems coupled with less chances of cross-contamination make single-use bioprocessing systems a prime purchase option for manufacturers involved in monoclonal antibody production.

Geographically, the global single-use bioprocessing systems market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries/sub-regions. A global overview has been provided, and North America has been analyzed in depth at country as well as product, application, and end-user segment levels. North America includes the U.S. and Canada. Europe, Asia Pacific, Latin America, and Middle East & Africa have been briefly profiled at country level. Countries/sub-regions in these regions include the U.K., Germany, France, Italy, Spain, China, Japan, Australia & New Zealand, Brazil, Mexico, GCC Countries, and South Africa. The competition matrix section included in the report is likely to assist existing players to increase market shares and new companies to establish presence in the global single-use bioprocessing systems market. The report also profiles major players in the global market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Thermo Fisher Scientific, Merck KGaA (Merck Millipore), Danaher Corporation (Pall Corporation), Sartorius AG, Eppendorf AG, GE Healthcare, PBS Biotech, Inc., Meissner Filtration Products, Finesse Solutions, Sentinel Process Solutions, and Saint-Gobain.

The global single-use bioprocessing systems market has been segmented as follows:

Global Single-use Bioprocessing Systems Market, by Product

  • Bioreactors & Fermenters
  • Mixers
  • Bags
  • Bioprocess Containers
  • Filtration Devices
  • Tubing
  • Sampling Systems
  • Connectors & Clamps
  • Probes & Sensors

Global Single-use Bioprocessing Systems Market, by End-user

  • Pharmaceutical
  • Biotechnology
  • CRO & CMO
  • Academic & Research Institutes

Global Single-use Bioprocessing Systems Market, by Application

  • Monoclonal Antibody Production
  • Vaccine Production
  • Plant Cell Cultivation
  • Patient Specific Cell Therapies
  • Others (production of enzymes, growth factors, etc.)

Global Single-use Bioprocessing Systems Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Note: Product cover images may vary from those shown
2 of 2
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary: Global Single-use Bioprocessing Systems Market

Chapter 4. Market Overview
4.1. Introduction & Overview of Processes
4.2. Comparison: Single-use vs. Stainless Steel Systems
4.3. Regulatory Scenario
4.4. Key Industry Developments
4.5. Average Pricing Analysis
4.6. Market Dynamics
4.6.1. Drivers
4.6.2. Restraints
4.6.3. Opportunity
4.7. Value Chain Analysis
4.8. Porter’s Five Forces Analysis
4.9. Value Chain Analysis

Chapter 5. Global Single-use Bioprocessing Systems Market Analysis and Forecast, by Product
5.1. Key Findings
5.2. Introduction
5.3. Market Size (US$ Mn) Forecast, by Product
5.3.1. Bioreactors
5.3.2. Mixers
5.3.3. Bags
5.3.4. Tubing
5.3.5. Filtration Devices
5.3.6. Bioprocess Containers
5.3.7. Sampling Systems
5.3.8. Connectors & Clamps
5.3.9. Probes & Sensors
5.4. Market Attractiveness Analysis, by Product, 2017
5.5. Key Trends

Chapter 6. Global Single-use Bioprocessing Systems Market Analysis and Forecast, by Application
6.1. Key Findings
6.2. Introduction
6.3. Market Size (US$ Mn) Forecast, by Application
6.3.1. Monoclonal Antibody Production
6.3.2. Vaccine Production
6.3.3. Plant Cell Cultivation
6.3.4. Patient Specific Cell Therapies
6.3.5. Others (recombinant proteins, enzymes, etc.)
6.4. Market Attractiveness Analysis, by Application, 2017
6.5. Key Trends

Chapter 7. Global Single-use Bioprocessing Systems Market Analysis and Forecast, by End-user
7.1. Key Findings
7.2. Introduction
7.3. Market Size (US$ Mn) Forecast, by End-user
7.3.1. Pharmaceutical
7.3.2. Biotechnology
7.3.3. CRO & CMO
7.3.4. Academic & Research Institutes
7.4. Market Attractiveness Analysis, by End-user, 2017
7.5. Key Trends

Chapter 8. Global Single-use Bioprocessing Systems Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Introduction
8.3. Market Size (US$ Mn) Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4. Market Attractiveness Analysis, by Region, 2017
8.5. Key Trends

Chapter 9. North America Single-use Bioprocessing Systems Market Analysis and Forecast
9.1. Key Findings
9.2. Introduction
9.3. Market Size (US$ Mn) Forecast, by Product
9.3.1. Bioreactors
9.3.2. Mixers
9.3.3. Bags
9.3.4. Tubing
9.3.5. Filtration Devices
9.3.6. Bioprocess Containers
9.3.7. Sampling Systems
9.3.8. Connectors & Clamps
9.3.9. Probes & Sensors
9.4. Market Size (US$ Mn) Forecast, by Application
9.4.1. Monoclonal Antibody Production
9.4.2. Vaccine Production
9.4.3. Plant Cell Cultivation
9.4.4. Patient Specific Cell Therapies
9.4.5. Others (recombinant proteins, enzymes, etc.)
9.5. Market Size (US$ Mn) Forecast, by Application
9.5.1. Pharmaceutical
9.5.2. Biotechnology
9.5.3. CRO & CMO
9.5.4. Academic & Research Institutes
9.6. Market Size (US$ Mn) Forecast, by Country
9.6.1. U.S.
9.6.2. Canada
9.7. Market Attractiveness Analysis, by Product, 2017
9.8. Market Attractiveness Analysis, by Application, 2017
9.9. Market Attractiveness Analysis, by End-user, 2017
9.10. Key Trends

Chapter 10. Europe Single-use Bioprocessing Systems Market Analysis and Forecast
10.1. Key Findings
10.2. Introduction
10.3. Market Size (US$ Mn) Forecast, by Product
10.3.1. Bioreactors
10.3.2. Mixers
10.3.3. Bags
10.3.4. Tubing
10.3.5. Filtration Devices
10.3.6. Bioprocess Containers
10.3.7. Sampling Systems
10.3.8. Connectors & Clamps
10.3.9. Probes & Sensors
10.4. Market Size (US$ Mn) Forecast, by Application
10.4.1. Monoclonal Antibody Production
10.4.2. Vaccine Production
10.4.3. Plant Cell Cultivation
10.4.4. Patient Specific Cell Therapies
10.4.5. Others (recombinant proteins, enzymes, etc.)
10.5. Market Size (US$ Mn) Forecast, by Application
10.5.1. Pharmaceutical
10.5.2. Biotechnology
10.5.3. CRO & CMO
10.5.4. Academic & Research Institutes
10.6. Market Size (US$ Mn) Forecast, by Country/Sub-region
10.6.1. U.K.
10.6.2. Germany
10.6.3. France
10.6.4. Italy
10.6.5. Spain
10.6.6. Rest of Europe
10.7. Market Attractiveness Analysis, by Product, 2017
10.8. Market Attractiveness Analysis, by Application, 2017
10.9. Market Attractiveness Analysis, by End-user, 2017
10.10. Key Trends

Chapter 11. Asia Pacific Single-use Bioprocessing Systems Market Analysis and Forecast
11.1. Key Findings
11.2. Introduction
11.3. Market Size (US$ Mn) Forecast, by Product
11.3.1. Bioreactors
11.3.2. Mixers
11.3.3. Bags
11.3.4. Tubing
11.3.5. Filtration Devices
11.3.6. Bioprocess Containers
11.3.7. Sampling Systems
11.3.8. Connectors & Clamps
11.3.9. Probes & Sensors
11.4. Market Size (US$ Mn) Forecast, by Application
11.4.1. Monoclonal Antibody Production
11.4.2. Vaccine Production
11.4.3. Plant Cell Cultivation
11.4.4. Patient Specific Cell Therapies
11.4.5. Others (recombinant proteins, enzymes, etc.)
11.5. Market Size (US$ Mn) Forecast, by Application
11.5.1. Pharmaceutical
11.5.2. Biotechnology
11.5.3. CRO & CMO
11.5.4. Academic & Research Institutes
11.6. Market Size (US$ Mn) Forecast, by Country/Sub-region
11.6.1. China
11.6.2. Japan
11.6.3. India
11.6.4. Australia & New Zealand
11.6.5. Rest of Asia Pacific
11.7. Market Attractiveness Analysis, by Product, 2017
11.8. Market Attractiveness Analysis, by Application, 2017
11.9. Market Attractiveness Analysis, by End-user, 2017
11.10. Key Trends

Chapter 12. Latin America Single-use Bioprocessing Systems Market Analysis and Forecast
12.1. Key Findings
12.2. Introduction
12.3. Market Size (US$ Mn) Forecast, by Product
12.3.1. Bioreactors
12.3.2. Mixers
12.3.3. Bags
12.3.4. Tubing
12.3.5. Filtration Devices
12.3.6. Bioprocess Containers
12.3.7. Sampling Systems
12.3.8. Connectors & Clamps
12.3.9. Probes & Sensors
12.4. Market Size (US$ Mn) Forecast, by Application
12.4.1. Monoclonal Antibody Production
12.4.2. Vaccine Production
12.4.3. Plant Cell Cultivation
12.4.4. Patient Specific Cell Therapies
12.4.5. Others (recombinant proteins, enzymes, etc.)
12.5. Market Size (US$ Mn) Forecast, by Application
12.5.1. Pharmaceutical
12.5.2. Biotechnology
12.5.3. CRO & CMO
12.5.4. Academic & Research Institutes
12.6. Market Size (US$ Mn) Forecast, by Country/Sub-region
12.6.1. Brazil
12.6.2. Mexico
12.6.3. Rest of Latin America
12.7. Market Attractiveness Analysis, by Product, 2017
12.8. Market Attractiveness Analysis, by Application, 2017
12.9. Market Attractiveness Analysis, by End-user, 2017
12.10. Key Trends

Chapter 13. Middle East & Africa Single-use Bioprocessing Systems Market Analysis and Forecast
13.1. Key Findings
13.2. Introduction
13.3. Market Size (US$ Mn) Forecast, by Product
13.3.1. Bioreactors
13.3.2. Mixers
13.3.3. Bags
13.3.4. Tubing
13.3.5. Filtration Devices
13.3.6. Bioprocess Containers
13.3.7. Sampling Systems
13.3.8. Connectors & Clamps
13.3.9. Probes & Sensors
13.4. Market Size (US$ Mn) Forecast, by Application
13.4.1. Monoclonal Antibody Production
13.4.2. Vaccine Production
13.4.3. Plant Cell Cultivation
13.4.4. Patient Specific Cell Therapies
13.4.5. Others (recombinant proteins, enzymes, etc.)
13.5. Market Size (US$ Mn) Forecast, by Application
13.5.1. Pharmaceutical
13.5.2. Biotechnology
13.5.3. CRO & CMO
13.5.4. Academic & Research Institutes
13.6. Market Size (US$ Mn) Forecast, by Country/Sub-region
13.6.1. GCC Countries
13.6.2. South Africa
13.6.3. Rest of Middle East & Africa
13.7. Market Attractiveness Analysis, by Product, 2017
13.8. Market Attractiveness Analysis, by Application, 2017
13.9. Market Attractiveness Analysis, by End-user, 2017
13.10. Key Trends

Chapter 14. Competition Landscape
14.1. Single-use Bioprocessing Systems Market Share Analysis, by Key Players, 2015
14.2. Competition Matrix
14.3. Company Profiles
14.4. Danaher Corporation (Pall Corporation)
14.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.2. Financial Overview
14.4.3. Product Portfolio
14.4.4. SWOT Analysis
14.4.5. Strategic Overview
14.5. Eppendorf AG
14.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.2. Financial Overview
14.5.3. Product Portfolio
14.5.4. SWOT Analysis
14.5.5. Strategic Overview
14.6. Finesse Solutions
14.6.1. Company Overview (HQ, business segments, employee strength)
14.6.2. Financial Overview
14.6.3. Product Portfolio
14.6.4. SWOT Analysis
14.6.5. Strategic Overview
14.7. GE Healthcare
14.7.1. Company Overview (HQ, business segments, employee strength)
14.7.2. Financial Overview
14.7.3. Product Portfolio
14.7.4. SWOT Analysis
14.7.5. Strategic Overview
14.8. Meissner Filtration Products, Inc.
14.8.1. Company Overview (HQ, business segments, employee strength)
14.8.2. Financial Overview
14.8.3. Product Portfolio
14.8.4. SWOT Analysis
14.8.5. Strategic Overview
14.9. Merck KGaA (Merck Millipore)
14.9.1. Company Overview (HQ, business segments, employee strength)
14.9.2. Product Portfolio
14.9.3. SWOT Analysis
14.9.4. Recent Developments
14.9.5. Strategic Overview
14.10. Parker Hannifin Corporation
14.10.1. Company Overview (HQ, business segments, employee strength)
14.10.2. Financial Overview
14.10.3. Product Portfolio
14.10.4. SWOT Analysis
14.10.5. Strategic Overview
14.11. PBS Biotech, Inc.
14.11.1. Company Overview (HQ, business segments, employee strength)
14.11.2. Financial Overview
14.11.3. Product Portfolio
14.11.4. SWOT Analysis
14.11.5. Strategic Overview
14.12. Saint Gobain
14.12.1. Company Overview (HQ, business segments, employee strength)
14.12.2. Product Portfolio
14.12.3. SWOT Analysis
14.12.4. Strategic Overview
14.12.5. Value Chain
14.13. Sartorius AG
14.13.1. Company Overview (HQ, business segments, employee strength)
14.13.2. Financial Overview
14.13.3. Product Portfolio
14.13.4. SWOT Analysis
14.13.5. Strategic Overview
14.14. Sentinel Process Systems
14.14.1. Company Overview (HQ, business segments, employee strength)
14.14.2. Financial Overview
14.14.3. Product Portfolio
14.14.4. SWOT Analysis
14.14.5. Partnerships for single-use systems
14.14.6. Strategic Overview
14.15. Thermo Fisher Scientific
14.15.1. Company Overview (HQ, business segments, employee strength)
14.15.2. Financial Overview
14.15.3. Product Portfolio
14.15.4. SWOT Analysis
14.15.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll